Mariacristina Ghioni

Medicine & Life Sciences

1. Malignant Mesothelioma 100%
2. Cervical Intraepithelial Neoplasia 99%
3. Neoplasm Antigens 87%
4. Endometrial Neoplasms 84%
5. Estrogen Receptors 76%
6. Ovary 71%
7. Carcinoma 68%
8. Lung Neoplasms 65%
9. Epidemiology 64%
10. Neoplasms 57%
11. Esophageal Squamous Cell Carcinoma 55%
12. Breast Neoplasms 52%
13. Lymph Nodes 46%
14. Adenomyosis 45%
15. Lung 44%
16. Neoplasm Metastasis 40%
17. Antigens 37%
18. Melanoma-Specific Antigens 32%
19. Multiple Pulmonary Nodules 32%
20. Triple Negative Breast Neoplasms 28%
21. Testicular Neoplasms 26%
22. Ultrasonography 25%
23. phosphatidylinositol 4,5-biphosphate kinase 23%
24. Time-to-Treatment 22%
25. Pleural Effusion 21%
26. Lymphadenopathy 21%
27. Diagnostic Errors 19%
28. Cytoreduction Surgical Procedures 17%
29. Endometrium 17%
30. Therapeutics 16%
31. Pathologists 16%
32. Ovarian Epithelial Carcinoma 15%
33. Biological Factors 14%
34. Endometriosis 14%
35. Platinum 14%
36. Adjuvant Chemotherapy 13%
37. Progesterone Receptors 12%
38. Catalytic Domain 12%
39. Genotype 11%
40. Histology 10%
41. Quality of Life 8%
42. Vaccines 8%
43. Monoclonal Antibodies 8%
44. Immunohistochemistry 8%
45. Drug Therapy 8%
46. Mutation 7%
47. Phenotype 7%
48. Antibodies 6%
49. Italy 5%
50. Routine Diagnostic Tests 5%